BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 27544425)

  • 1. What is the Optimum Screening Strategy for the Early Detection of Lung Cancer.
    Baldwin DR; Callister ME
    Clin Oncol (R Coll Radiol); 2016 Nov; 28(11):672-681. PubMed ID: 27544425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening and management.
    Jones GS; Baldwin DR
    Minerva Med; 2015 Dec; 106(6):339-54. PubMed ID: 26605556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review.
    Puggina A; Broumas A; Ricciardi W; Boccia S
    Eur J Public Health; 2016 Feb; 26(1):168-75. PubMed ID: 26370440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evidence for low-dose CT screening of lung cancer.
    Ruchalski K; Gutierrez A; Genshaft S; Abtin F; Suh R
    Clin Imaging; 2016; 40(2):288-95. PubMed ID: 26362352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
    Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
    Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.
    Goulart BH; Ramsey SD
    Oncologist; 2013; 18(8):941-6. PubMed ID: 23873718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.
    Goulart BH; Bensink ME; Mummy DG; Ramsey SD
    J Natl Compr Canc Netw; 2012 Feb; 10(2):267-75. PubMed ID: 22308519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rationale for, and design of, a lung cancer screening program.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79(5):337-45. PubMed ID: 22550076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose computed tomography screening reduces lung cancer mortality.
    Ostrowski M; MarjaĊ„ski T; Rzyman W
    Adv Med Sci; 2018 Sep; 63(2):230-236. PubMed ID: 29425790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the cancer risk management model lung cancer screening module.
    Flanagan WM; Evans WK; Fitzgerald NR; Goffin JR; Miller AB; Wolfson MC
    Health Rep; 2015 May; 26(5):11-8. PubMed ID: 25993046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current estimate of costs of lung cancer screening in the United States.
    Mauchley DC; Mitchell JD
    Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.
    Raymakers AJN; Mayo J; Lam S; FitzGerald JM; Whitehurst DGT; Lynd LD
    Appl Health Econ Health Policy; 2016 Aug; 14(4):409-418. PubMed ID: 26873091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A National Survey of Pulmonologists' Views on Low-Dose Computed Tomography Screening for Lung Cancer.
    Iaccarino JM; Clark J; Bolton R; Kinsinger L; Kelley M; Slatore CG; Au DH; Wiener RS
    Ann Am Thorac Soc; 2015 Nov; 12(11):1667-75. PubMed ID: 26368003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer screening: advantages, controversies, and applications.
    Nanavaty P; Alvarez MS; Alberts WM
    Cancer Control; 2014 Jan; 21(1):9-14. PubMed ID: 24357736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.
    Gou HF; Liu Y; Yang TX; Zhou C; Chen XZ
    Oncotarget; 2017 Jan; 8(1):1788-1795. PubMed ID: 27705946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.
    Lancaster HL; Heuvelmans MA; Oudkerk M
    J Intern Med; 2022 Jul; 292(1):68-80. PubMed ID: 35253286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
    Silva M; Pastorino U; Sverzellati N
    Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose computed tomography screening for lung cancer: results of the first screening round.
    Horeweg N; Nackaerts K; Oudkerk M; de Koning HJ
    J Comp Eff Res; 2013 Sep; 2(5):433-6. PubMed ID: 24236740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.